Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells

被引:34
作者
Yue, Meng [1 ]
Li, Shiquan [1 ]
Yan, Guoqiang [1 ]
Li, Chenyao [1 ]
Kang, Zhenhua [1 ]
机构
[1] Jilin Univ, Dept Colorectal & Anal Surg, Hosp 1, Changchun 130021, Jilin, Peoples R China
关键词
FoxM1; colorectal cancer; Paeoniflorin; proliferation; cell cycle; invasion; FORKHEAD BOX M1; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR FOXM1; DOWN-REGULATION; TUMOR INVASION; PROTEIN M1; IN-VITRO; PROLIFERATION; APOPTOSIS; METASTASIS;
D O I
10.1080/15384101.2017.1407892
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Paeoniflorin (PF) exhibits tumor suppressive functions in a variety of human cancers. However, the function of PF and molecular mechanism in colorectal cancer are elusive. In the present study, we investigated whether PF could exert its antiproliferative activity, anti-migration, and anti-invasive function in colorectal cancer cells. We found that PF inhibited cell growth and induced apoptosis and blocked cell cycle progression in the G0/G1 phase in colorectal cancer cells. Moreover, we found that PF suppressed cell migration and invasion in colorectal cancer cells. FoxM1 has been reported to play an important oncogenic role in human cancers. We also determine whether PF inhibited the expression of FoxM1, leading to its anti-cancer activity. We found that PF treatment in colorectal cancer cells resulted in down-regulation of FoxM1. The rescue experiments showed that overexpression of FoxM1 abrogated the tumor suppressive function induced by PF treatment. Notably, depletion of FoxM1 promoted the anti-tumor activity of PF in colorectal cancer cells. Therefore, inhibition of FoxM1 could participate in the anti-tumor activity of PF in colorectal cancer cells.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 56 条
[1]   FOXM1: A key oncofoetal transcription factor in health and disease [J].
Bella, Laura ;
Zona, Stefania ;
de Moraes, Gabriela Nestal ;
Lam, Eric W. -F. .
SEMINARS IN CANCER BIOLOGY, 2014, 29 :32-39
[2]   Paeoniflorin exerts neuroprotective effects against glutamate-induced PC12 cellular cytotoxicity by inhibiting apoptosis [J].
Chen, Ahong ;
Wang, Hongyun ;
Zhang, Yuqin ;
Wang, Xiaoying ;
Yu, Lishuang ;
Xu, Wen ;
Xu, Wei ;
Lin, Yu .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (03) :825-833
[3]   FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer [J].
Chu, Xiao-Yuan ;
Zhu, Zi-Man ;
Chen, Long-Bang ;
Wang, Jing-Hua ;
Su, Quan-Sheng ;
Yang, Ji-Rong ;
Lin, Yong ;
Xue, Li-Jun ;
Liu, Xiao-Bei ;
Mo, Xiao-Bei .
ACTA HISTOCHEMICA, 2012, 114 (08) :755-762
[4]   Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-κB activation [J].
Fang, Shencun ;
Zhu, Wei ;
Zhang, Yingming ;
Shu, Yongqian ;
Liu, Ping .
MOLECULAR MEDICINE REPORTS, 2012, 5 (02) :351-356
[5]   FOXM1 in Cancer: Interactions and Vulnerabilities [J].
Gartel, Andrei L. .
CANCER RESEARCH, 2017, 77 (12) :3135-3139
[6]   Protective, effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice [J].
Gu, Peiqing ;
Zhu, Lei ;
Liu, Yajun ;
Zhang, Lu ;
Liu, Junlou ;
Shen, Hong .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 50 :152-160
[7]   Targeting FOXM1 in cancer [J].
Halasi, Marianna ;
Gartel, Andrei L. .
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (05) :644-652
[8]   Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation [J].
Hao, Jian ;
Yang, Xue ;
Ding, Xiu-li ;
Guo, Lei-ming ;
Zhu, Cui-hong ;
Ji, Wei ;
Zhou, Tong ;
Wu, Xiong-zhi .
SCIENTIFIC REPORTS, 2016, 6
[9]   Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis [J].
Hu, Shanshan ;
Sun, Wuyi ;
Wei, Wei ;
Wang, Di ;
Jin, Juan ;
Wu, Jingjing ;
Chen, Jingyu ;
Wu, Huaxun ;
Wang, Qingtong .
ANTI-CANCER DRUGS, 2013, 24 (02) :140-149
[10]   FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis [J].
Huang, Chen ;
Du, Jiawei ;
Xie, Keping .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02) :104-116